Natural Statins and Stroke Risk
- 19 January 1999
- journal article
- editorial
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 99 (2), 185-188
- https://doi.org/10.1161/01.cir.99.2.185
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Reduction of Stroke Incidence After Myocardial Infarction With PravastatinCirculation, 1999
- HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials dataAtherosclerosis, 1998
- Antiatherothrombotic Properties of StatinsJama-Journal Of The American Medical Association, 1998
- Comparative Dose Efficacy Study of Atorvastatin Versus Simvastatin, Pravastatin, Lovastatin, and Fluvastatin in Patients With Hypercholesterolemia (The CURVES Study)The American Journal of Cardiology, 1998
- Infarctlike lesions in the brain: prevalence and anatomic characteristics at MR imaging of the elderly--data from the Cardiovascular Health Study.Radiology, 1997
- Surrogate End Points in Clinical Trials: Are We Being Misled?Annals of Internal Medicine, 1996
- Efficacy and Safety of a New HMG-CoA Reductase Inhibitor, Atorvastatin, in Patients With HypertriglyceridemiaJAMA, 1996
- Cholesterol, diastolic blood pressure, and stroke: 13 000 strokes in 450 000 people in 45 prospective cohortsThe Lancet, 1995
- Preliminary Report of the Stroke Prevention in Atrial Fibrillation StudyNew England Journal of Medicine, 1990
- Serum Cholesterol Levels and Six-Year Mortality from Stroke in 350,977 Men Screened for the Multiple Risk Factor Intervention TrialNew England Journal of Medicine, 1989